Sunday, November 13, 2016

Roche announces positive results for Actemra in phase III study

VIENNA, Nov 13 (Reuters) - Swiss drugmaker Roche

said on Sunday its rheumatoid arthritis medication Actemra for

giant cell arteritis showed to be superior to steroids alone in

maintaining...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)